MedPath
NMPA Approval

Rifampicin for Injection

国药准字H20244279

June 28, 2024

Drug Information

注射用利福平

注射剂

0.6g

化学药品

June 28, 2024

Company Information

Applicant Company

重庆市南岸区江峡路1号10幢

Manufacturing Company

天津开发区黄海路221号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用利福平 - NMPA 批准文号 | MedPath